Anticoagulation During RRT in the ICU

  • Vimal Chadha
  • Bradley A. WaradyEmail author


A 10-year-old boy presented to the Emergency Department with a history of fever and abdominal pain of 2 days’ duration. His parents reported that his condition worsened over the past few hours as he became lethargic and looked pale, and his abdomen was distended. On examination, he was lethargic and febrile (39.5 °C; 103 °F) with a heart rate of 140/min and blood pressure 90/50 mmHg, and his respirations were slow with minimal movement of the abdominal wall. His abdomen was distended, and there was guarding and tenderness on palpation. He received two 0.9% saline (20 mL/kg) fluid boluses, and he was taken to the operating room for evaluation of a presumed surgical abdomen. During surgery, he was found to have a perforated appendix and purulent peritoneal fluid. He was subsequently admitted to the PICU where he was on mechanical ventilation and received vasopressors (epinephrine and norepinephrine) for blood pressure support. He also received broad-spectrum antibiotics with coverage for anaerobic organisms. Over the next 24 h, he became 15% fluid overloaded as his urine output progressively decreased to anuria over 12 h. His serum chemistries revealed sodium 143 mEq/L, potassium 5.6 mEq/L, chloride 98 mEq/L, bicarbonate 17 mEq/L, urea nitrogen 48 mg/dL, creatinine 2.4 mg/dL, and calcium 8.9 mg/dL. Hematology labs revealed hemoglobin 8.6 g/dL and WBC count 22,000 with platelet count of 66,000/mm3. A nephrology consult was obtained for management of acute kidney injury (AKI).


  1. 1.
    Kaddourah A, Basu RK, Bagshaw SM, Goldstein SL, for the AWARE Investigators. Epidemiology of acute kidney injury in critically ill children and young adults. NEJM. 2017;376:11–20.CrossRefGoogle Scholar
  2. 2.
    Sethi SK, Sinha R, Jha P, et al. Feasibility of sustained low efficiency dialysis in critically sick pediatric patients: a multicentric retrospective study. Hemodial Int. 2018;22(20):228–34.CrossRefGoogle Scholar
  3. 3.
    Tan HK, Baldwin I, Bellomo R. Continuous veno-venous hemofiltration without anticoagulation in high-risk patients. Intensive Care Med. 2000;26:1652–7.CrossRefGoogle Scholar
  4. 4.
    The VA/NIH Acute Renal Failure Trial Network. Intensity of renal support in critically ill patients with acute kidney injury. NEJM. 2008;26:1652–7.Google Scholar
  5. 5.
    van de Wetering J, Westendrop RG, ven der Hoeven JG, et al. Heparin use in continuous renal replacement procedures: the struggle between filter coagulation and patient hemorrhage. J Am Soc Nephrol. 1996;7:145–50.PubMedGoogle Scholar
  6. 6.
    Oudemans-Van Straaten HM, Wester JP, et al. Anticoagulation strategies in continuous renal replacement therapy: can the choice be evidence based? Intensive Care Med. 2006;32:188–202.CrossRefGoogle Scholar
  7. 7.
    Ward DM, Mehta RL. Extracorporeal management of acute renal failure patients at high-risk of bleeding. Kidney Int. 1993;43(Suppl 41):237–44.Google Scholar
  8. 8.
    Maher JF, Lapierre L, Schreiner GE, et al. Regional heparinization for hemodialysis. N Engl J Med. 1963;268:451.CrossRefGoogle Scholar
  9. 9.
    Uchino S, Fealy N, Baldwin I, et al. Continuous venovenous hemofiltration without anticoagulation. ASAIO J. 2004;50:76–80.CrossRefGoogle Scholar
  10. 10.
    Gattas DJ, Rajbhandari D, Bradford C, et al. A randomized controlled trial of regional citrate versus regional heparin anticoagulation for continuous renal replacement therapy in critically ill adults. Crit Care Med. 2015;43(8):1622–9.CrossRefGoogle Scholar
  11. 11.
    Hetzel GR, Sucker C. The heparins: all a nephrologist should know. Nephrol Dial Transplant. 2005;20:2036–42.CrossRefGoogle Scholar
  12. 12.
    Schrader J, Stibbe W, Kandt M, et al. Low molecular weight heparin versus standard heparin. A long-term study in hemodialysis and hemofiltration patients. ASAIO Trans. 1990;36:28–32.PubMedGoogle Scholar
  13. 13.
    Murray PT, Reddy BV, Grossman EJ, et al. A prospective comparison of three argatroban treatment regimens during hemodialysis in end-stage renal disease. Kidney Int. 2004;66:2446.CrossRefGoogle Scholar
  14. 14.
    Link A, Girndt M, Selejan S, et al. Argatroban for anticoagulation in continuous renal replacement therapy. Crit Care Med. 2009;37:105.CrossRefGoogle Scholar
  15. 15.
    Kiser TH, MacLaren R, Fish DN, et al. Bivalirudin versus unfractionated heparin for prevention of hemofilter occlusion during continuous renal replacement therapy. Pharmacotherapy. 2010;30:1117.CrossRefGoogle Scholar
  16. 16.
    Langenecker SA, Felfernig M, Werba A, et al. Anticoagulation with prostacyclin and heparin during continuous venovenous hemofiltration. Crit Care Med. 1994;22:1774.CrossRefGoogle Scholar
  17. 17.
    Nakae H, Tajimi K. Pharmacokinetics of nafamostat mesilate during continuous hemodiafiltration with a polyacrylonitrile membrane. Ther Apher Dial. 2003;7:483.CrossRefGoogle Scholar
  18. 18.
    Mehta RL, McDonald BR, Aguilar MM, et al. Regional citrate anticoagulation for continuous arteriovenous hemodialysis in critically ill patients. Kidney Int. 1990;38:976–81.CrossRefGoogle Scholar
  19. 19.
    Bai M, Zhou M, He L, et al. Citrate versus heparin anticoagulation for continuous renal replacement therapy: an updated meta-analysis of RCTs. Intensive Care Med. 2015;41:2098.CrossRefGoogle Scholar
  20. 20.
    Tolwani AJ, Campbell RC, Schenk MB, et al. Simplified citrate anticoagulation for continuous renal replacement therapy. Kidney Int. 2001;60:370–4.CrossRefGoogle Scholar
  21. 21.
    Chadha V, Garg U, Warady BA, et al. Citrate clearance in children receiving continuous veno-venous replacement therapy. Pediatr Nephrol. 2002;17:819–24.CrossRefGoogle Scholar
  22. 22.
    Meier-Kriesche HU, Gitomer J, Finkel K, et al. Increased total to ionized calcium ratio during continuous venovenous hemodialysis with regional citrate anticoagulation. Crit Care Med. 2001;29:748–52.CrossRefGoogle Scholar

Copyright information

© Springer Nature Singapore Pte Ltd. 2019

Authors and Affiliations

  1. 1.Department of PediatricsUniversity of Missouri – Kansas City School of MedicineKansas CityUSA
  2. 2.Division of Pediatric NephrologyChildren’s Mercy Kansas CityKansas CityUSA

Personalised recommendations